Q
Qinfu Feng
Researcher at Peking Union Medical College
Publications - 126
Citations - 1310
Qinfu Feng is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Radiation therapy & Medicine. The author has an hindex of 14, co-authored 98 publications receiving 831 citations.
Papers
More filters
Journal ArticleDOI
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
Jun Liang,Nan Bi,S. Wu,Ming Chen,C. Lv,L. Zhao,A. Shi,Wei Jiang,Yaomin Xu,Zongmei Zhou,Wei Wang,Dongfu Chen,Zhouguang Hui,J. Lv,Hongxing Zhang,Qinfu Feng,Zefen Xiao,Xin Wang,Lipin Liu,Tao Zhang,Liping Du,Wei Chen,Yu Shyr,Weibo Yin,Jian Li,Jie He,Luhua Wang +26 more
TL;DR: EP might be superior to weekly PC in terms of OS in the setting of concurrent chemoradiation for unresectable stage III NSCLC.
Journal ArticleDOI
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial
Zhouguang Hui,Yu Men,Chen Hu,J. Kang,J. Kang,Xin Sun,Nan Bi,Zongmei Zhou,Jun Liang,Jima Lv,Qinfu Feng,Zefen Xiao,Dongfu Chen,Yan Wang,Junling Li,Jie Wang,Shugeng Gao,Luhua Wang,Jie He +18 more
TL;DR: The PORT-C randomized clinical trial was conducted in 394 patients with pIIIA-N2 non-small cell lung cancer (NSCLC) treated with complete resection and 4 cycles of platinum-based chemotherapy between January 2009 and December 2017.
Journal ArticleDOI
Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis.
Hui Zhu,Zongmei Zhou,Yan Wang,Nan Bi,Qinfu Feng,Junling Li,Jima Lv,Dongfu Chen,Yuankai Shi,Luhua Wang +9 more
TL;DR: The authors conducted a retrospective study to evaluate the effects of thoracic radiation therapy (TRT) for patients with extensive‐stage small cell lung cancer (ED‐SCLC).
Journal ArticleDOI
Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution
Honghai Dai,Zhouguang Hui,W. Ji,Jun Liang,Ji-ma Lü,Guangfei Ou,Zongmei Zhou,Qinfu Feng,Zefen Xiao,Dongfu Chen,Hongxing Zhang,Weibo Yin,Jie He,Luhua Wang +13 more
TL;DR: PORT can significantly improve the survival of patients with resected pathological stage IIIA-N2 NSCLC and a prospective randomized multicenter clinical trial is ongoing.
Journal ArticleDOI
Risk Factors for Brain Metastases in Locally Advanced Non-Small Cell Lung Cancer With Definitive Chest Radiation
Zhe Ji,Nan Bi,Jingbo Wang,Zhouguang Hui,Zefen Xiao,Qinfu Feng,Zongmei Zhou,Dongfu Chen,Jima Lv,Jun Liang,Chengcheng Fan,Lipin Liu,Luhua Wang +12 more
TL;DR: Age ≤60 years, non-squamous cell carcinoma, serum NSE >18 ng/mL, and CA125 ≥ 35 U/mL were independent risk factors for brain metastasis and the possibilities of selectively using prophylactic cranial irradiation in higher-risk patients with LA-NSCLC should be further explored in the future.